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The signal-sequence receptor (SSR) has previously been shown to be a component of the environment which 
nascent polypeptides meet on passage through the endoplasmic reticulum (ER) membrane. We report here on the 
primary structure of the SSR as deduced from cDNA clones and from direct protein sequencing. The glycoprotein 
is synthesized with a cleavable amino-terminal signal sequence and contains only one classical membrane-spanning 
segment. Its insertion into the ER membrane during biosynthesis depends on the function of the signal-recognition 
particle. SSR shows a remarkable charge distribution with the amino terminus being highly negatively charged, 
and the cytoplasmic carboxyl terminus positively charged. The SSR can be phosphorylated in its cytoplasmic tail 
both in intact cells and in a cell-free system, suggesting a regulation of its function. The localization of the protein 
in the ER membrane was confirmed by immunofluorescence microscopy. 
Protein translocation across the endoplasmic reticulum 
membrane is initiated by an interaction of the signal sequence 
of the nascent polypeptide with the 54-kDa polypeptide 
component of the signal-recognition particle (SRP) [l - 31. 
Association with the membrane is mediated by the affinity of 
SRP for its receptor in the ER membrane, also called docking 
protein [4, 51, which has recently been shown to be a GTP- 
binding protein [6]. On interaction with its receptor, the SRP 
is released from both the ribosome [7] and from the signal 
sequence [S] and the latter is transferred into close proximity 
of an integral, glycosylated membrane protein of molecular 
mass z 34 kDa, called the signal-sequence receptor [9]. Identi- 
fication of the SSR was based on a photocrosslinking ap- 
proach whereby a photoreactive lysine derivative was intro- 
duced into the signal sequence of nascent preprolactin and 
crosslinking to the SSR was induced by irradiation [2 ,  91. 
Using the same technique, it has been recently shown that not 
only the signal sequence but also the succeeding part of 
nascent proprolactin is located in proximity to the SSR during 
translocation [lo]. This result indicates that the SSR is a 
component of the environment which nascent polypeptide 
chains meet on passage through the ER membrane. SSR may 
be a constituent of a postulated translocation complex 
through which the nascent chain traverses the membrane. 
On the basis of the properties of the SSR as deduced from 
crosslinking experiments, we have purified a 34-kDa integral 
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membrane glycoprotein from dog pancreatic microsomes [l 11. 
Identity with the SSR is indicated by the fact that antibodies 
to the purified protein recognize the crosslinked products [lo]. 
The SSR is present in the ER membrane of various types 
of cells of different species in excess over membrane-bound 
ribosomes [lo], in keeping with its assumed role as a constitu- 
ent of the translocation complex. The protein appears to be 
essential for translocation since antibodies directed against it 
and Fab fragments prepared from the antibodies inhibit the 
translocation of several secretory proteins in vitro [l 11. 
It is obviously of great interest to obtain structural infor- 
mation on the SSR. Is it a tunnel protein similar in structure 
to the ion channels or electron transporters (for review, see 
[12])? Given the fact that macromolecules should pass through 
the postulated translocation complex, one may expect com- 
pletely different features. Indeed, we report here that the pri- 
mary structure of the SSR does not contain multiple mem- 
brane-spanning segments with amphipathic helical character. 
The protein has only one classical membrane-spanning seg- 
ment and displays a remarkable charge distribution with the 
N-terminus highly negatively charged and the C-terminus 
positively charged. Insertion of the SSR into the ER mem- 
brane during biosynthesis depends on the function of the SRP. 
We have also found that the SSR is phosphorylated at its 
cytoplasmic tail. 
MATERIALS AND METHODS 
Amino acid sequencing 
SSR was purified from canine microsomes extracted with 
alkali by concanavalin-A - Sepharose chromatography as 
described [ll]. The eluted glycoproteins were separated in 
10% SDS/polyacrylamide gels, the proteins were electro- 
blotted onto nitrocellulose and stained with Ponceau S. 
Sequencing of tryptic peptides of the SSR was carried out 
according to Aebersold et al. [13]. CNBr-peptides of gel-eluted 
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SSR were separated by HPLC and subjected to automated 
sequencing. 
cDNA cloning, screening and nucleotide sequencing 
A cDNA library was prepared from cytoplasmic poly(A)- 
rich RNA, isolated from MDCK (Madin Darby canine kid- 
ney) cells, essentially as described by Haymerle et al. 1141. The 
double-stranded cDNA was ligated to adaptors and cloned 
into the BamHI site of the bacterial expression vector pTEX. 
pTEX is a derivative of the pEX/pUEX vector family (J. Herz 
et al., unpublished results). 
Hydridization screening of colonies was carried out a& 
cording to Maniatis et al. 1151 with the following two 
oligonucleotides: 5'-AT(A/G)TA(A/G)AA(T/C)TG(A/G)- 
TA(A/G)TC(T/C)TG-3' and 5'-TT(A/G)TTNGCNGG(A/ 
G)AA(A/G)TC(T/C)TC-3' (N indicates that all four bases 
were inserted at that position), corresponding to the peptides 
QDYQFYI and EDFPANN, respectively. The probes were 
end-labeled with [Y-~~P]ATP and polynucleotide kinase and 
hybridized in 6 x SSC (SSC: 0.15 M NaCl, 15 mM trisodium 
citrate, pH 7.0) at 42 "C. Washing was carried out with 4 x SSC 
at 37°C. 
Immunoscreening with antibodies to the SSR [I 11 was 
carried out according to Stanley and Luzio [I61 after growth 
of the colonies at 42 "C. 
Hind111 and Pstl fragments of the positive clones were 
cloned into MI3 mp18 and 19 and both DNA strands were 
sequenced by the Sanger method with sequenase (United 
States Biochemical, manufacturer's protocol). Some regions 
were analyzed by the use of internal oligonucleotide primers 
synthesized according to the already known sequence. 
Cell-free transcriptionltranslation 
The insert of a SSR clone was cut out with the restriction 
enzyme NotI, the ends were filled in with Klenow enzyme and 
the DNA fragment cloned into the SmaI site of the vector 
pGEM2. In vitro transcription was carried out with T7-RNA 
polymerase as described by Melton et al. for SP6 polymerase 
[17]. Translation in a wheat germ cell-free system was 
performed with [35S]methionine (>  50 TBq/mmol) as labelled 
amino acid as described 181. Salt-washed microsomes (K-RM) 
and SRP were isolated as described [IS, 191 and added at 
final concentrations of 4 Azso  unit/ml or 0.03 A260 unit/ml, 
respectively. The glycosylation competitor peptide Bz-Asn- 
Leu-Thr-NH-Me [20] was used at a final concentration of 
30 pM. Posttranslational proteolysis was carried out with 
0.3 mg/ml proteinase K for 1 h a t  0°C. Where indicated, 0.3% 
Nonidet P-40 was added. 
Transient expression of SSR in CV-I cells 
and immunofluorescence microscopy 
The insert of a SSR-clone was recloned into the vector 
pSVL51 [21] under a simian virus 40 promoter. CV-1 cells 
were transfected using the DEAE-Dextran method [22]. Cells 
were labelled overnight with [3sS]methionine (7.4 MBq/lO-cm 
dish) two days after transfection. Lysis of the cells was carried 
out with a buffer containing 20 mM Tris/HCl pH 7.5,150 mM 
NaCl, 2 mM MgCl,, 2 mM CaCl,, 1% Nonidet P-40 and 
1 mM phenylmethylsulfonyl fluoride. Immunoprecipitation 
with antiserum to the SSR [Il l  was carried out as described 
using protein-A - Sepharose to collect the antigen . antibody 
complexes [9]. 
Indirect immunofluorescence microscopy was performed 
with antibodies against SSR and tetramethylrhodamine- 
isothiocyanate-labelled second antibodies directed against 
rabbit immunoglobulin. 
Phosphorylation of the SSR 
For phosphorylation in intact cells, MDCK cells 
( M 5 x lo6) were incubated with [32P]phosphate (18.5 MBq/ 
ml) for 2 h in medium lacking serum. The cells were lysed and 
the proteins subjected to immunoprecipitation with antiserum 
to SSR. 
Cell-free phosphorylation was performed in a 25 pl assay 
containing 20 mM Hepes/KOH, pH 7.5, 100 mM NaCl, 
2 mM MgClz and 0.2 MBq of [y-32P]ATP. One equivalent of 
microsomes was added. Where indicated wheat germ extract 
(z 10 pg protein) and inhibitor of the CAMP-dependent pro- 
tein kinase (8 pg) were also added. Incubations were carried 
out at 0 "C for 20 min. For alkaline extraction, 150 p10.15 M 
Na2C03 were added. After 10 min incubation in ice, the 
samples were centrifuged in a Beckman Airfuge for 10 min at 
0.14 MPa. The pellets were dissolved in 2% SDS and analyzed 
by SDS gel electrophoresis according to Laemmli [23]. 
Wheat germ postribosomal supernatant was obtained 
from an extract by centrifugation at I00000 xg,, for 1 h. 
Peptide antibodies and immunoblots 
Antibodies to a peptide comprising the C-terminal 15 
amino acids of the SSR were raised in rabbits after coupling 
to keyhole-limpet hemocyanine with glutaraldehyde. Immu- 
noblot analysis of electrophoretically separated microsomal 
proteins was carried out as described [Ill. 
RESULTS 
Amino acid sequencing 
The 34-kDa protein (SSR) was isolated from canine micro- 
somes as described previously [ll]. Partial amino acid se- 
quences were obtained from purified peptides obtained by 
cleavage of the SSR with trypsin or CNBr. The amino ter- 
minus of the protein could not be determined since it was 
found to be blocked. 
The partial amino acid sequence obtained for the SSR is 
shown in parenthesis in Fig. 1 below the nucleotide sequence 
of the cDNA. 
cDNA cloning 
Two oligonucleotides were synthesized, the sequences of 
which were based on those of two of the tryptic peptides (see 
Materials and Methods). The probes were end-labelled and 
used to screen a MDCK-cell cDNA library cloned into the 
vector pTEX [I41 (Herz et al., unpublished results). 
MDCK cells have been derived from dog kidney and have 
been used previously to clone the SRP receptor [24]. The 
synthesis of SSR in these cells could be demonstrated by 
immunoprecipitation after metabolic labelling with [35S]- 
methionine (data not shown). The vector pTEX can also be 
used to screen with antibodies for the temperature-sensitive 
expression of a fusion between /3-galactosidase and the desired 
protein. 
Among approximately 150000 independent recombinants 
screened, 25 were found to hybridize with both oligonucleotide 
44 1 
Pr0t.K: - + - + 
a(C-pept.):  - - + + 
a(SSR): + + - - 
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L6- 
30- 
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Fig. 2. Antibodies to a C-terminal peptide recognize a cytosolic domain 
ofSSR.  Microsomdl membranes from dog pancreas (two equivalents) 
were either treated with proteinase K (Prot. K;  0.1 mg/ml, 10 min, 
25°C; lanes 2 and 4) or remained untreated (lanes 1 and 3). The 
proteins were analyzed after SDS/PAGE by immunoblotting with 
antibodies directed against intact SSR, a(SSR) [ll] (lanes 1 and 2), or 
against a peptide comprising thc C-terminal 15 amino acids, a(C- 
pept.; lanes 3 and 4; see Fig. 1). The numbers give the molecular mass 
of marker proteins 
acid sequence derived from the cDNA clones. The calculated 
isoelectric point (pH 4.1) is in good aggreement with that 
determined experimentally [l l] .  
Further proof that the correct protein has been cloned 
was obtained by producing antibodies to a synthetic peptide 
comprising the C-terminal 15 amino acids (indicated in bold 
face in Fig. 1). Imunoblots demonstrate that the antibodies 
recognize the SSR in microsomes (Fig. 2, lane 3). If micro- 
somes were pretreated with a high concentration of protease, 
the reactivity was lost (Fig. 2, lane 4), whereas the antibodies 
against the intact SSR reacted with the protein fragment 
(cf. lanes 1 and 2) .  These data indicate that the epitope of the 
SSR recognized by the peptide antibodies is exposed to the 
cytosol. 
The sequence upstream Of the assumed initiator methi'- 
nine is very similar to the COnSenSuS sequence (GCCGCC(A/ 
G ) C C m )  determined by Kozak [251 to be present at most 
sites of translation initiation in eukaryotic mRNA. 
In order to provide additional proof that the clones contain 
the entire coding sequence of the SSR, the DNA was recloned 
under the simian virus 40 promoter and expressed in CV-1 
cells. The cells were incubated with [35Slmethionine, lysed 
Fig. 1. Nucleotide and amino acid sequence of the SSR. The nucleotide 
sequence was determined from cloned cDNA. The amino acid se- 
quence derived from it is shown above, and that determined directly 
is given below (given in parenthesis in the one-letter code). The se- 
quence of a synthetic peptide against which antibodies were raised is 
given in bold face. Hydrophobic amino acid sequences are underlined. 
Potential glycosylation sites are indicated by (CHO) 
probes. Except for two clones, the inserts all had a size of 
about 2 kb and contained the same sequence according to 
cross-hybridization data (not shown). The two exceptional 
clones had inserts of about 4 kb which were identical in se- 
quence at their 5'-ends to the smaller clones. They may perhaps 
represent clones of nonspliced pre-mRNA. Among the posi- 
tive clones with z 2 kb inserts, two were found to express a 
fusion protein after temperature induction which reacted with 
antibodies to the 34-kDa SSR (data not shown). One of these 
clones was subcloned into MI3 and sequenced. In addition, 
one of the z 2-kb clones that did not give an immunoreactive 
fusion protein was also sequenced. The nucleotide sequences 
were identical except for the number of bases at the extreme 
5'-untranslated terminus (Fig. 1 shows the sequence common 
under non-denaturing conditions and the -proteins subjected 
to immunoprecipitation with antibodies to the 34-kDa SSR 
(Fig. 3). The overexpressed SSR had exactly the same size as 
the endogenous protein (Fig. 3, arrow, cf. lanes 1 and 2 with 
lane 3). A band of slightly slower mobility seen after over- 
expression presumably represents a precursor polypeptide 
from which the signal sequence has not yet been removed (see 
below). It should also be noted that two other polypeptides of 
lower and higher molecular mass were coimmunoprecipitated 
under these conditions (Fig. 3, see arrow head and bar). The 
smaller one appears to be identical with a recently discovered 
z22-kDa protein that is tightly bound to the SSR (D. 
Goerlich et al., unpublished results); the nature of the larger 
protein is unclear as yet. 
to both clones). 
The amino acid sequence derived from the nucleotide se- Properties O f t h e  SSR sequence 
quence is in good agreement with that directly determined 
(Fig. 1). All the peptides sequenced were found in the amino 
The amino acid sequence reveals two potential sites for N- 
linked glycosylation (Fig. 1). According to the hydrophobicity 
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transf.: + + - S R P ' -  - + - + + + + + + + +  
K-RM:-  - - + +  + + + + + + +  
pept.:- - - - - - - - + + + +  
prot : -  - - - -  - + + - - + +  
, jet:-  - - - - - - + - - - +  
+ - -  1p:- - - - - + - - - 
68- 
L6 - 
30- 
.46 
-30 
- 18 
f. 
4 
18- 
1 2 3  
Fig. 3. Expression of SSR in CV-I cells. CV-1 cells were transfected 
(transf.) with a clone containing the SSR sequence under a simian 
virus 40 promoter. The cells were labelled with [35S]methionine, lysed 
under non-denaturing conditions and the proteins subjected to 
immunoprecipitation with SSR antibodies. The proteins were sepa- 
rated by SDSjPAGE and visualized by fluorography. Lanes l and 2 
show the results of two independent experiments; lane 3 shows a 
control with nontransfected cells. The arrow indicates the position of 
the SSR, the arrow head and the bar that of two other polypeptides 
which were coprecipitated 
scales of Kyte and Doolittle [26] and of Eisenberg et al. [27] 
there are two possible membrane-spanning segments, one 
close to the N-terminus and one between residues 207 and 
230. The latter domain is a classical membrane-anchor se- 
quence. Its orientation must be such that the amino terminus 
faces the lumen of the ER and the carboxyl terminus the 
cytosol. This orientation is deduced from the position of the 
potential N-glycosylation sites (lumen of the ER) and from 
the fact that extensive proteolysis of microsomal membranes 
cleaves off about 7 kDa from the SSR [l 11 which would corre- 
spond to the 56-amino-acid residues following the membrane- 
spanning segment. Furthermore, the data shown in Fig. 2 also 
demonstrate that the C-terminal residues are accessible to 
proteolytic attack. 
In order to test if the N-terminal hydrophobic segment 
represents a cleavable signal sequence, the cDNA was recloned 
into the pGEM vector under the T7-polymerase promoter and 
used in cell-free transcription/translation experiments (Fig. 4). 
A translation product of about 35 kDa was obtained in the 
wheat germ system (Fig. 4, lane 2). If translation was carried 
out in the presence of SRP, the synthesis was severely inhibited 
(Fig. 4, lane 3). A similar translational inhibition by SRP has 
been observed for many other secretory and membrane pro- 
teins (for review, see Rapoport [28]). If the system was com- 
plemented by microsomal membranes depleted of SRP by 
extraction with high salt (K-RM), the inhibition was partially 
released and a band at 34 kDa, at the same position as natural 
SSR, was seen (Fig. 4, lane 5) which was in part immuno- 
precipitable (lane 6). K-RMs alone did not produce this band 
(Fig. 4, lane 4). If core glycosylation was prevented by ad- 
dition of a competitor peptide [20], the main translation prod- 
uct had a size of about 30 kDa (Fig. 4, lane 9); it was re- 
cognized by SSR antibodies (lane 10). The data indicate that 
1 2  3 4 5  6 7 8 9  10 I I I L  
Fig. 4. In vitro insertion of SSR into rnicrosomal membranes. RNA 
coding for the SSR was synthesized by in vitro transcription and 
translated in a wheat germ cell-free system (lanes 2 - 12). Sample 1 
did not receive RNA. SRP, salt-washed canine microsomes (K-RM) 
and a peptide competitively inhibiting glycosylation (pept.) were 
added to the incubations as indicated. After translation, post- 
translational proteolysis with proteinase K (prot.) was carried out in 
the presence or absence of detergent (det.) as indicated. The products 
were either analyzed directly by SDSjPAGE or after immuno- 
precipitation with SSR antibodies (IP, lanes 6 and 10). The dots 
indicate the bands of interest 
two carbohydrate chains, each contributing z 2 kDa, are pre- 
sent in the 34-kDa protein. Whenever microsomes were pre- 
sent during translation, the product lost about 5 - 7 kDa after 
treatment with protease (Fig. 4, lanes 7 and 11). If proteolysis 
was carried out in the presence of detergent, the proteins were 
totally degraded (Fig. 4, lanes 8 and 12). These results show 
that the SSR is integrated into the ER membrane with a 
cleavable signal peptide in a SRP-dependent fashion, that it 
spans the membrane with the second hydrophobic domain, 
and that it contains two carbohydrate chains. 
The exact cleavage site of the signal peptidase remains 
unclear as yet since the amino terminal residue(s) of the mature 
protein could not be determined. Predictions are difficult since 
no site conforming to the - 1, - 3 rule [29] can be found. In 
any case, most if not all of the highly negatively charged 
region following the N-terminal hydrophobic segment must be 
present in the mature protein to explain its low isoelectric 
point [ll]. 
The charge distribution in the SSR sequence is indeed its 
most remarkable feature. The amino terminal region contains 
23 negative charges in a segment of 35 residues, whereas the 
carboxyl terminal portion following the second hydrophobic 
domain is predominantly positively charged (Fig. 1). 
The SSR can be phosphorylated 
Since the function of the SSR in the translocation process 
may be modulated under certain conditions, we have tested 
the possibility that it is phosphorylated. MDCK cells were 
incubated with radioactive inorganic phosphate, lysed and the 
proteins subjected to immunoprecipitation with antibodies to 
the SSR (Fig. 5). Indeed a labelled band at the expected po- 
sition was observed (Fig. 5 ,  lane 16) which was absent if 
nonimmune serum was used as a control (lane 15). 
Phosphorylation of the SSR could also be demonstrated 
in a cell-free system (Fig. 5 ,  lanes 1 - 14). If crude microsomal 
membranes were incubated with [ Y - ~ ~ ] A T P  many labelled 
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cell free system 
68 - 
46 - 
29- 
- MDCKCOIIS dependent kinase phosphroylated the SSR nor did EGTA 
inhibit phosphorylation by wheat germ extract, indicating that 
NS AS NS tot the calmodulin-dependent kinase also was not involved (data 
+ +  not shown). - -  
_ _  - -  
The SSR is located in the ER - -  
Previous data suggested the ER localization of the SSR 
on the basis of its abundance in microsomal preparations 
from dog pancreas. This conclusion could be confirmed by 
immunofluorescence microscopy using specific antibodies 
(Fig. 6). The figure shows an ER-typical, network-like stain- 
ing of CV-1 cells transiently expressing the SSR. A similar 
staining pattern, although much weaker, may be seen in neigh- 
bouring cells with a low expression level. 
Q n 12 13 14 1516 17 1 2  3 4 5 6 7  8 
Fig. 5. Phosphorylation ofthe SSR. Phosphorylation of the SSR was 
carried out either in a cell-free system with [y-32P]ATP (lanes 1 - 14) 
or in intact MDCK cells with [32P]phosphate (lanes 15 - 17). Where 
indicated, immunoprecipitation with antiserum against SSR (AS) or 
with non-immune serum (NS) was carried out. The other samples were 
analyzed either after precipitation with trichloroacetic acid (TCA) or 
after alkaline extraction of the membranes. In the in vitro reactions, 
either crude microsomes (crude RM) or salt-washed microsomes 
(K-RM) were used. Wheat germ postribosomal supernatant (WG), a 
specific inhibitor of the CAMP-dependent protein kinase (CAMP-K.- 
Inh.) and unlabelled ATP were added as indicated. The arrow head 
indicates the position of SSR 
bands could be seen (Fig. 5 ,  lane l), some of which, including 
that of SSR, were resistent to alkaline extraction (lane 2). 'The 
identity of the labelled SSR was proven by immunoprecipita- 
tion (cf. Fig. 5 ,  lanes 13 and 14). Low concentrations of 
unlabelled ATP were sufficient to abolish the phosphorylation 
(Fig. 5,  lanes 9- 12). The kinase responsible for the phosphor- 
ylation appears to be peripherally bound to the microsomes 
since extensive washing with high salt removed the activity 
(Fig. 5,  lane 7). The SSR in thouroughly washed microsomes 
could be phosphorylated by a kinase present in wheat germ 
postribosomal supernatant (Fig. 5 ,  lane 8) although the band 
was less prominent than in experiments with crude micro- 
somes. Some of the labelled bands appeared to be identical 
but there were also differences in the overall pattern (e.g. 
Fig. 5, cf. lanes 8 and 9), indicating that different kinases are 
involved. If no unlabelled ATP was added in experiments with 
wheat germ extract, a major band was seen but phosphor- 
ylated SSR could not be detected (Fig. 5 ,  lane 4). As expected, 
no labelled bands were seen in the alkaline extracted pellet in 
the absence of membranes (Fig. 5,  lane 3). The phosphate in 
the SSR was found in the cytosolic tail; all the label was lost 
after proteolysis. Most of the phosphate was attached to serine 
(data not shown). Phosphorylation could also be observed 
with [32P]GTP but it cannot be excluded as yet that transfer 
of the label to ATP (or vice vevsu in the experiments with 
labelled ATP) had occurred. 
Phosphorylation was not catalyzed by the CAMP-depen- 
dent kinase since a specific inhibitor [30] did not have any 
effect (Fig. 5 ,  cf. lanes 5 and 6). Also, neither isolated CAMP- 
DISCUSSlON 
We have determined the primary structure of the SSR, an 
essential component of the protein translocation complex of 
the ER membrane. The amino acid sequence did not show 
any apparent homology to any of the sequences in the EMBL 
Sequence Data Library (release 19, May 1989). Also, there is 
no similarity to the 54-kDa polypeptide component of the 
SRP [31, 321 which interacts with signal sequences [2, 31. Thus 
although the signal sequence of nascent preprolactin is close 
to the SSR during translocation, a specific binding in the same 
way as suggested for the 54-kDa polypeptide appears to be 
unlikely. The photocrosslinking of the signal sequence does 
not occur with the cytoplasmic domain of the SSR [lo], in 
agreement with the fact that its sequence is short and highly 
charged. The possibility remains that other portion(s) of the 
SSR have an affinity for signal sequences. 
Our belief that SSR is part of a translocation complex 
appears at variance with the fact that only one classical mem- 
brane-spanning segment could be identified rather than sev- 
eral amphipathic helices as is typical for ion and electron 
channels [I 21. However, one may expect a protein-translocat- 
ing tunnel to be quite different from the rather rigid structures 
produced by the association of amphipathic helices. It may 
be assumed to be more flexible since preprolactin can be 
translocated across the ER membrane even if bulky biotin 
groups are attached to the side chains of its lysines [33]. For 
mitochondria evidence exists that even branched, crosslinked 
proteins and proteins linked to oligonucleotides are able to 
cross membranes [34]. 
The membrane topology of the SSR seems to be such that 
the hydrophobic segment comprising residues 207 - 230 spans 
the membrane with its N-terminus located in the lumen of the 
ER and its C-terminus in the cytoplasm. The role of the 
remarkable charge distribution, with the lumenal portion 
negatively charged and the cytoplasmic portion positively 
charged, is unclear as yet. It may be in the build up of a local 
membrane potential. For protein translocation across the 
cytoplasmic membrane in Eschevichia coli and for protein 
import into mitochondria the function of a bulk membrane 
potential has been demonstrated [35, 361. Although such a 
potential is probably not required for protein translocation 
across the ER membrane since ionophores have no effect 
[37, 381 (our unpublished results), a local potential could con- 
ceivably be involved. 
The structure of the SSR suggests that it cannot be the 
only component of a presumed translocation complex. The 
fact that two polypeptides were coimmunoprecipitated with 
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Fig. 6. Cellular localization of the SSR analyzed by immunofluorescence microscopy. CV-1 cells were transfected with a clone expressing SSR 
under a simian virus 40 promoter. The localization of SSR was analyzed by immunofluorescence microscopy using antibodies to the SSK and 
tetramethylrhodamine-isothiocyanate-labelled second antibodies 
SSR antibodies suggests that indeed other components are 
tightly bound. One of them, a ~ 2 2 - k D a  glycoprotein, has 
been purified recently and shown to form a stable complex 
with the SSR (D. Goerlich et al., unpublished data). Thus, 
SSR may well be a component of a larger complex. 
We have also found that SSR is phosphorylated in its 
cytoplasmic tail. It is tempting to speculate that phosphoryla- 
tion regulates the translocation process. For example, phos- 
phorylation or dephosphorylation may induce the formation 
or the opening of the tunnel. Since wheat germ contains a SSR 
kinase, it appears possible that phosphorylation occurs in the 
in vitro translation/translocation system. However, fur- 
ther work, including purification of the kinase, is required to 
prove a role for a phosphorylation cycle in the translocation 
process. 
It is interesting that the membrane insertion of the SSR 
depends on the function of the SRP. This is in contrast to the 
biosynthesis of another membrane component of the translo- 
cation apparatus, the a-subunit of the SRP receptor, which is 
independent of SRP [39, 401. Our results show that synthesis 
of a translocation component depends on the prior existence 
of a translocation system (a specification of the old statement 
of R. Virchow: ‘omnis cellulu e cellulu’ [41]). 
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